Biblio

33557 resultats trouvés
C
Wolking S, May P, Mei D, Moller RS, Balestrini S, Helbig KL, Altuzarra CDesmettre, Chatron N, Kaiwar C, Stohr K et al..  2019.  Clinical spectrum of STX1B-related epileptic disorders. NEUROLOGY. 92:E1238-E1249.
Jachiet V, Moulis G, Hadjadj J, Seguier J, Laribi K, Schleinitz N, Vey N, Sacre K, Godeau B, Beyne-Rauzy O et al..  2021.  Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. HAEMATOLOGICA. 106:1414-1422.
Denis J, Villeneuve N, Cacciagli P, Mignon-Ravix C, Lacoste C, Lefranc J, Napuri S, Damaj L, Villega F, Pedespan J-M et al..  2019.  Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures. EPILEPSIA. 60:845-856.
Romanet P, Guy M, Allaert F-A.  2018.  Clinical study on the efficacy, acceptance, and safety of hearing aids in patients with mild to moderate presbyacusis. PANMINERVA MEDICA. 60:92-100.
Fauque P, Lehert P, Lamotte M, Bettahar-Lebugle K, Bailly A, Diligent C, Cledat M, Pierrot P, Guenedal M-L, Sagot P.  2014.  Clinical success of intrauterine insemination cycles is affected by the sperm preparation time. FERTILITY AND STERILITY. 101:1618-U465.
Libois V., Mahe M.-A, Rio E., Maingon P..  2016.  Clinical to target volume margins determination in radiotherapy for anal cancers. CANCER RADIOTHERAPIE. 20:645-650.
Jacob CMehler, Poulat ALise, Ribrault A, Roubertie A, Frache S, Sevin C, Gabolde M.  2018.  Clinical trials or palliative care: Do we have to choose? MEDECINE PALLIATIVE. 17:314-322.
Raber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, Radu MD, Joner M, Yu B, Jia H et al..  2018.  Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EUROINTERVENTION. 14:656-677.
Raber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, Radu MD, Joner M, Yu B, Jia H et al..  2018.  Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EUROPEAN HEART JOURNAL. 39:3281-3300.
Arslan-Kirchner M, Arbustini E, Boileau C, Charron P, Child AH, Collod-Beroud G, De Backer J, De Paepe A, Dierking A, Faivre L et al..  2016.  Clinical utility gene card for: Hereditary thoracic aortic aneurysm and dissection including next-generation sequencing-based approaches. EUROPEAN JOURNAL OF HUMAN GENETICS. 24:146-150.
Thierry A.R, S. Messaoudi E, Mollevi C., Raoul J.L, Guimbaud R., Pezet D., Artru P., Assenat E., Borg C., Mathonnet M. et al..  2017.  Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment. ANNALS OF ONCOLOGY. 28:2149-2159.
Bidard F-C, Jacot W., Dureau S., Brain E., Bachelot T., Bourgeois H., Goncalves A., Ladoire S., Naman H., Dalenc F. et al..  2019.  Clinical utility of circulating tumor cell count as a tool to chose between first line hormone therapy and chemotherapy for ER+HER2-metastatic breast cancer: Results of the phase III STIC CTC trial. CANCER RESEARCH. 79
Marisa L, Ayadi M, Balogoun R, Pilati C, Le Malicot K, Lepage C, Emile J-Francois, Salazar R, Aust DEllen, Duval A et al..  2017.  Clinical utility of colon cancer molecular subtypes: Validation of two main colorectal molecular classifications on the PETACC-8 phase III trial cohort.. JOURNAL OF CLINICAL ONCOLOGY. 35
Bernard-Tessier A, Jeannot E, Guenat D, Debernardi A, Michel M, Proudhon C, Vincent-Salomon A, Bieche I, Pierga J-Y, Buecher B et al..  2019.  Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial. CLINICAL CANCER RESEARCH. 25:2109-2115.
Gonssaud B, Goussot V, Berriolo-Riedinger A, Saitta-Aribau E, Coutant C, Cochet A, Fumoleau P, Riedinger J-M.  2017.  Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer. ANNALES DE BIOLOGIE CLINIQUE. 75:421-429.
Konan S, Goussot V, Desmoulins I, Lorgis V, Coutant C, Fumoleau P, Beltjens F, Dalban C, Lizard S, Riedinger J-M.  2015.  Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer. BULLETIN DU CANCER. 102:834-844.
Maccio G, Goussot V, Berriolo-Riedinger A, Riedinger J-M.  2017.  Clinical value of CEA for detection of distant metastases in newly diagnosed breast cancer: comparison with CA 15-3. ANNALES DE BIOLOGIE CLINIQUE. 75:431-441.
Gandemer V, Pochon C, Oger E, Dalle J-HH, Michel G, Schmitt C, de Berranger E, Galambrun C, Cave H, Cayuela J-M et al..  2014.  Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol. BRITISH JOURNAL OF HAEMATOLOGY. 165:392–401.
Nambot S, Thevenon J, Kuentz P, Duffourd Y, Tisserant E, Bruel A-L, Mosca-Boidron A-L, Masurel-Paulet A, Lehalle D, Jean-Marcais N et al..  2018.  Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis. GENETICS IN MEDICINE. 20:645-654.
Mariotte E., Azoulay E., Galicier L., Rondeau E., Zouiti F., Boisseau P., Poullin P., Demaistre E., Provot F., Delmas Y. et al..  2016.  Clinical-biological-genetic features of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency: the french experience. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 14:145.
Devilliers H., Jolly M..  2015.  Clinically Meaningful Change Estimates for Generic Patient Reported Tools Used in SLE against various disease activity endpoints. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 33:S37.
Devilliers H., Jolly M..  2015.  Clinically Meaningful Change Estimates for Generic Patient Reported Tools Used in SLE against various disease activity endpoints. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 33:S37.
Sparano F, Aaronson NK, Cottone F, Piciocchi A, La Sala E, Anota A, Deliu N, Kieffer JM, Efficace F.  2019.  Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes? JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 8:279-288.
Gailllard B., Cornillet-Lefebvre P., Maloum K., Pannetier M., Lecoq-Lafon C., Gabillaud C., Lesty C., Nadal N., Ittel A., Struski S. et al..  2017.  CLINICOBIOLOGICAL FEATURES OF B-CELL NEOPLASMS WITH CDK6 TRANSLOCATIONS: FREQUENT ASSOCIATION WITH MARGINAL-ZONE LYMPHOMA, CONTINGENT OF PROLYMPHOCYTIC CELLS AND TP53 ABNORMALITIES. A GFCH STUDY. HAEMATOLOGICA. 102:560.
Traschuetz A, Schirinzi T, Laugwitz L, Murray NH, Bingman CA, Reich S, Kern J, Heinzmann A, Vasco G, Bertini E et al..  2020.  Clinico-Genetic, Imaging and Molecular Delineation of COQ8A-Ataxia: A Multicenter Study of 59 Patients. ANNALS OF NEUROLOGY. 88:251-263.

Pages